bpc-157 is overrated Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing BPC-157

BPC 157 antagonized portal/caval hypertension (caval portal hypertension), and aortal hypotension, refractory ascites and thrombosis (portal vein tributaries, inferior vena cava, hepatic and coronary arteries), pathology of the lungs (severe capillary congestion) and liver (dilated central veins and terminal portal venules), intestine hemorrhagic lesions (substantial capillary congestion, submucosal edema and architecture loss), increased liver and spleen weight serum and enzymes values, NO- and MDA-levels in the liver

DISPOSE OF THE SYRINGE AND NEEDLE SAFELY USING THE SAFE-CLIP

Clinical Trials Multicenter, randomized controlled trial: To verify the efficacy and safety of AOD 9604 in humans

Quit or cut back

Treat Endocrinol